syngo.CT Extended Functionality
Siemens Medical Solutions USA, Inc. • Radiology • 07/13/2022
Device Purpose
The syngo.CT Extended Functionality is a software package designed to enhance diagnostic capabilities by providing advanced visualization and quantitative analysis tools for medical images, primarily from CT scanners. It employs various image processing extensions, including recent updates incorporating deep learning for vascular imaging and expanded ROI functionalities for spectral and oncological analysis, to support clinicians in detailed clinical evaluations.
Summary
The syngo.CT Extended Functionality is a software package designed to aid technicians and physicians in diagnosing medical conditions by providing advanced visualization tools for processing medical images. It supports qualitative and quantitative measurements and the analysis of clinical data acquired from Computed Tomography (CT) scanners and potentially other imaging modalities like Magnetic Resonance (MR) scanners. The software functions through a collection of "Extensions," which are specific tools tailored for various clinical evaluations, and an interface connects it to the CT scanner system, enabling seamless data transfer and image processing. The current software version, SOMARIS/8 VB70, introduces several enhancements. A new "Average" extension allows pixel-by-pixel averaging of two DICOM images, whether from the same or different series. The "Vessel" extension now incorporates a deep learning algorithm for improved bone removal in head and neck vascular evaluations. The "Interactive Spectral Imaging" extension has expanded its Region of Interest (ROI) support to include circular and elliptical ROIs, along with other shapes for dual-energy data representation. Furthermore, the "Oncology" extension now permits the display of spectral information for arbitrarily shaped ROIs, enhancing nodule localization and evaluation. Other existing extensions for trauma, osteo, neuro DSA, ROI HU threshold, dual energy, endoscopic viewing, and pulmonary density (which uses an AI algorithm for lung opacity segmentation) remain unchanged.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the deep learning algorithm in the "Vessel" extension improve the accuracy and efficiency of bone removal compared to traditional image processing techniques, particularly in complex head and neck anatomies?; What is the quantifiable impact of the new "Average" extension on image noise reduction or signal enhancement, and in what specific clinical scenarios is this pixel-by-pixel averaging most beneficial?; For the "Interactive Spectral Imaging" and "Oncology" extensions, how does the expanded support for various ROI shapes (circular, elliptic, freehand, auto contour, polygonal, arbitrarily shaped) enhance the precision of dual-energy data analysis and tumor characteristic assessment?; Are there any comparative studies demonstrating the diagnostic performance improvement or workflow efficiency gains when using the syngo.CT Extended Functionality (SOMARIS/8 VB70) compared to its predicate version or other similar image processing software?; Given the use of AI in the "Pulmonary Density" extension and deep learning in the "Vessel" extension, what is the validation process for these algorithms, especially concerning diverse patient populations and image acquisition protocols?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SBOM, ML-BOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly